Prostate Survival Outcomes

The chart below shows the relative five-year survival rates for patients diagnosed at RPCI from 2000-2004, a period for which national comparison data are available. Most patients with stage II or III prostate cancer will die from some other cause.

This chart reveals a five-year survival benefit for patients treated at RPCI across all stages of disease, which reflects the quality of care provided.